The impact of grade grubbing on teachers typically isn’t positive—many reported feeling uncomfortable with the requests and ...

While studying salmon populations and designing amusement parks, these students are breaking barriers to advanced math that ...

Discover why Lineage (LINE) leads cold storage with tech-driven cost advantages, strong dividends, and growth potential.

Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.

When governments panic, they legislate. When they legislate in panic, they create monsters. Australia’s world-first ban on social media for under-16s, which came into force on 10 December, 2025, is ...

John Campbell is a senior vice president at Walt Disney Co. who oversees streaming ad sales. He also coaches his second-grade daughter's basketball team and recently asked ...

Apple is turning the flat photo into a new computing primitive. With its SHARP model, the company says a single snapshot can be transformed into a navigable 3D scene in less than a second on standard ...

"The Amazing Race" reality TV show awarded the winning prize of $1 million to a team of brothers this week, but former Miss Michigan USA Taylor Hale and her partner finished second on the ...

Kenya National Examinations Council(KNEC) CEO Dr.David Njengere addressing the media during the release of Kenya Junior Schools Education Assessment(KJSEA) at the KNEC Headquarters in Nairobi on ...

In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction in the risk of death or disease progression if they received epcoritamab ...

Wright Twp. supervisors are considering creating the position of township manager. An ordinance establishing the job will be one of three pieces of legislation on the supervisors’ agenda at their ...

Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular lymphoma. The EPCORE FL-1 trial results show a 79% progression-free ...